The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...
KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of the universal Covid-19 vaccine candidate, ...
New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do researchers quickly update shots to keep up with mutations?
The global ruminant vaccines market, valued at USD 3.51 billion in 2023, is projected to grow significantly at a compound annual growth rate (CAGR) of 6.95% from 2024 to 2032. Read the Market Summary ...
DNA Script, a leader in enzymatic DNA synthesis, today announced the appointment of Marc Montserrat as its new Chief Executive Officer. In addition, founding CEO Thomas Ybert, PhD, has transitioned to ...
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...